PRAME Kit CLIA
-
- Antigène Voir toutes PRAME Kits CLIA
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Reactivité
- Humain
- Méthode de détection
- Chemiluminescent
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 0.312 ng/mL - 20 ng/mL
- Seuil minimal de détection
- 0.312 ng/mL
- Application
- ELISA
- Fonction
- Human Preferentially Expressed Antigen In Melanoma (PRAME) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
- Type d'échantillon
- Cell Culture Supernatant, Cell Lysate, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensibilité
- < 0.117 ng/mL
- Top Product
- Discover our top product PRAME Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes PRAME Kits CLIA
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Abstract
- PRAME Produits
- Synonymes
- PRAME Kit CLIA, CT130 Kit CLIA, MAPE Kit CLIA, OIP-4 Kit CLIA, OIP4 Kit CLIA, 4930534P07Rik Kit CLIA, preferentially expressed antigen in melanoma Kit CLIA, PRAME Kit CLIA, Prame Kit CLIA
- Pathways
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
-